Literature DB >> 2498883

Intercellular adhesion molecule 1 is induced on isolated endocrine islet cells by cytokines but not by reovirus infection.

I L Campbell1, A Cutri, D Wilkinson, A W Boyd, L C Harrison.   

Abstract

The selective destruction of the pancreatic islet beta cells in type 1 diabetes mellitus is thought to be mediated by a cellular autoimmune process, possibly triggered by virus infection in genetically susceptible individuals. Because of the potentially important role of cell-cell adhesion in the immune response, we investigated whether cytokine products of mononuclear cells, or virus infection, induced the expression of intercellular adhesion molecule 1 (ICAM-1) on human endocrine islet cells. By flow cytofluorimetry, control islet cells did not express detectable ICAM-1. However, after a 72-hr exposure of islets to interferon gamma (IFN-gamma) and/or tumor necrosis factor alpha (TNF-alpha) (each at 250 units/ml), ICAM-1 was induced on greater than 85% of islet cells. IFN-gamma was 50% more potent than TNF-alpha; together, their effects were additive. Class I major histocompatibility complex (MHC) protein expression, detected on control islet cells, was also stimulated by IFN-gamma and/or TNF-alpha. In contrast, infection with reovirus type 3 did not induce ICAM-1 on islet cells, although it stimulated the expression of class I MHC proteins. By double-label indirect immunofluorescence microscopy, ICAM-1 expression was identified on both beta (insulin-secreting) and delta (somatostatin-secreting) islet cells. Monoclonal antibody to ICAM-1 precipitated protein of Mr 97,000 from [35S]methionine-labeled islets exposed to IFN-gamma and TNF-alpha, but not from control islets. RNA blot analysis revealed a major species of 3.3 kilobases and a minor species of 2.2 kilobases induced in islets exposed to the cytokines. These findings have implications for the molecular mechanisms of beta-cell destruction in type 1 diabetes, in that expression of ICAM-1 by beta cells may facilitate adhesion of antigen-targeted immune cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2498883      PMCID: PMC287435          DOI: 10.1073/pnas.86.11.4282

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon.

Authors:  J S Pober; M A Gimbrone; L A Lapierre; D L Mendrick; W Fiers; R Rothlein; T A Springer
Journal:  J Immunol       Date:  1986-09-15       Impact factor: 5.422

2.  Virus-induced diabetes mellitus: reovirus infection of pancreatic beta cells in mice.

Authors:  T Onodera; A B Jenson; J W Yoon; A L Notkins
Journal:  Science       Date:  1978-08-11       Impact factor: 47.728

3.  Evidence for specific association between class I major histocompatibility antigens and the CD8 molecules of human suppressor/cytotoxic cells.

Authors:  M L Blue; K A Craig; P Anderson; K R Branton; S F Schlossman
Journal:  Cell       Date:  1988-07-29       Impact factor: 41.582

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Monoclonal antibody to a novel lymphocyte function-associated antigen (LFA-1): mechanism of blockade of T lymphocyte-mediated killing and effects on other T and B lymphocyte functions.

Authors:  D Davignon; E Martz; T Reynolds; K Kürzinger; T A Springer
Journal:  J Immunol       Date:  1981-08       Impact factor: 5.422

6.  Evidence for functional domains on the reovirus type 3 hemagglutinin.

Authors:  S J Burstin; D R Spriggs; B N Fields
Journal:  Virology       Date:  1982-02       Impact factor: 3.616

7.  Antigen presentation by normal B cells, B cell tumors, and macrophages: functional and biochemical comparison.

Authors:  R W Chesnut; S M Colon; H M Grey
Journal:  J Immunol       Date:  1982-04       Impact factor: 5.422

8.  Aberrant expression of HLA-DR antigens by insulin-containing beta-cells in recent-onset type I diabetes mellitus.

Authors:  A K Foulis; M A Farquharson
Journal:  Diabetes       Date:  1986-11       Impact factor: 9.461

9.  The pancreatic islets in diabetes.

Authors:  W Gepts; P M Lecompte
Journal:  Am J Med       Date:  1981-01       Impact factor: 4.965

10.  Lymphocyte function-associated antigen 1 (LFA-1): a surface antigen distinct from Lyt-2,3 that participates in T lymphocyte-mediated killing.

Authors:  D Davignon; E Martz; T Reynolds; K Kürzinger; T A Springer
Journal:  Proc Natl Acad Sci U S A       Date:  1981-07       Impact factor: 11.205

View more
  30 in total

1.  Prevention of reovirus type 2-induced diabetes-like syndrome in DBA/1 suckling mice by treatment with antibodies against intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1.

Authors:  T Hayashi; S Yamamoto; T Onodera
Journal:  Int J Exp Pathol       Date:  1995-12       Impact factor: 1.925

Review 2.  Resolving the conundrum of islet transplantation by linking metabolic dysregulation, inflammation, and immune regulation.

Authors:  Xiaolun Huang; Daniel J Moore; Robert J Ketchum; Craig S Nunemaker; Boris Kovatchev; Anthony L McCall; Kenneth L Brayman
Journal:  Endocr Rev       Date:  2008-07-29       Impact factor: 19.871

Review 3.  MHC class II-associated variation in the production of tumor necrosis factor in mice and humans: relevance to the pathogenesis of autoimmune diseases.

Authors:  C O Jacob; G D Lewis; H O McDevitt
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

4.  Transforming growth factor beta decreases the immunogenicity of rat islet xenografts (rat to mouse) and prevents rejection in association with treatment of the recipient with a monoclonal antibody to interferon gamma.

Authors:  J C Carel; R D Schreiber; L Falqui; P E Lacy
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

5.  High-resolution, noninvasive longitudinal live imaging of immune responses.

Authors:  Midhat H Abdulreda; Gaetano Faleo; Ruth Damaris Molano; Maite Lopez-Cabezas; Judith Molina; Yaohong Tan; Oscar A Ron Echeverria; Elsie Zahr-Akrawi; Rayner Rodriguez-Diaz; Patrick K Edlund; Ingo Leibiger; Allison L Bayer; Victor Perez; Camillo Ricordi; Alejandro Caicedo; Antonello Pileggi; Per-Olof Berggren
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-18       Impact factor: 11.205

Review 6.  The role of interleukin-1 in the pathogenesis of IDDM.

Authors:  T Mandrup-Poulsen
Journal:  Diabetologia       Date:  1996-09       Impact factor: 10.122

7.  Rapid identification of fluorochrome modification sites in proteins by LC ESI-Q-TOF mass spectrometry.

Authors:  Prakash Manikwar; Tahl Zimmerman; Francisco J Blanco; Todd D Williams; Teruna J Siahaan
Journal:  Bioconjug Chem       Date:  2011-06-07       Impact factor: 4.774

8.  Characterization and functional analysis of the expression of intercellular adhesion molecule-1 in human papillomavirus-related disease of cervical keratinocytes.

Authors:  N Coleman; I M Greenfield; J Hare; H Kruger-Gray; B M Chain; M A Stanley
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

9.  Cytokines in sera from insulin-dependent diabetic patients at diagnosis.

Authors:  M G Cavallo; P Pozzilli; C Bird; M Wadhwa; A Meager; N Visalli; A J Gearing; D Andreani; R Thorpe
Journal:  Clin Exp Immunol       Date:  1991-11       Impact factor: 4.330

10.  Interleukin-1 promotes hyperglycemia and insulitis in mice normally resistant to streptozotocin-induced diabetes.

Authors:  S J Zunino; L F Simons; J F Sambrook; M J Gething
Journal:  Am J Pathol       Date:  1994-09       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.